A right mesh - what's left for stress incontinence?
It would seem rare in medicine to be able to summarise the future prospects of two separate classes of active surgical therapies with a simple yes or no.
However, that appears to be the situation with mid-urethral tapes for female stress urinary incontinence and transvaginal mesh for pelvic organ prolapse surgery (see figure 1 below).
Mid-urethral tapes have been in use for more than 20 years and transvaginal mesh for more than 10 years.
Both have been used in pelvic floor surgeries that attempted to advance efficacy for their respective clinical indications, hopefully with low complication profiles.
These therapies have been in the spotlight recently, thanks to extensive publicity generated from class actions and public enquiries around the world that related to complications from transvaginal mesh surgeries.